Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes

Molecular Immunology

Volumn 45, Issue 4, 2008, Pages 1056-1062

  Esposito, Marianna ^a   Luccarini, Ilaria ^b   Cicatiello, Valeria ^a   De Falco, Diana ^a   Fiorentini, Anna ^b   Barba, Pasquale ^a   Casamenti, Fiorella ^b   Prisco, Antonella ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's Disease; Immunotherapy; Vaccine

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-7]; AMYLOID BETA PROTEIN[2-6]; AMYLOID BETA PROTEIN[23-29]; AMYLOID BETA PROTEIN[4-11]; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; DNA FLANKING REGION; DRUG EFFICACY; IMMUNIZATION; IMMUNOGENICITY; LIPID STORAGE; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; COLIPHAGES; EPITOPES; IMMUNOTHERAPY; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; SENILE PLAQUES;

EID: 35548960991     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.07.023     Document Type: Article

References (16)

1. Antzutkin O.N., Balbach J.J., and Tycko R. Site-specific identification of non-beta-strand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR. Biophys. J. 84 (2003) 3326-3335
2. Frenkel D., Balass M., and Solomon B. N-terminal EFRH sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies. J. Neuroimmunol. 88 (1998) 85-90
3. Frenkel D., Dewachter I., Van Leuven F., and Solomon B. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. Vaccine 21 (2003) 1060-1065
4. Frenkel D., Dori M., and Solomon B. Generation of anti-beta-amyloid antibodies via phage display technology. Vaccine 22 (2004) 2505-2508
5. Frenkel D., Kariv N., and Solomon B. Generation of auto-antibodies towards Alzheimer's disease vaccination. Vaccine 19 (2001) 2615-2619
6. Frenkel D., Katz O., and Solomon B. Immunization against Alzheimer's beta-amyloid plaques via EFRH phage administration. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11455-11459
7. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., Copeland N.G., Lee M.K., Younkin L.H., Wagner S.L., Younkin S.G., and Borchelt D.R. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13 (2004) 159-170
8. Lavie V., Becker M., Cohen-Kupiec R., Yacoby I., Koppel R., Wedenig M., Hutter-Paier B., and Solomon B. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials. J. Mol. Neurosci. 24 (2004) 105-113
9. Malik P., and Perham R.N. Simultaneous display of different peptides on the surface of filamentous bacteriophage. Nucleic Acids Res. 25 (1997) 915-916
10. McLaurin J., Cecal R., Kierstead M.E., Tian X., Phinney A.L., Manea M., French J.E., Lambermon M.H., Darabie A.A., Brown M.E., Janus C., Chishti M.A., Horne P., Westaway D., Fraser P.E., Mount H.T., Przybylski M., and St George-Hyslop P. Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat. Med. 8 (2002) 1263-1269
11. Monsonego A., Maron R., Zota V., Selkoe D.J., and Weiner H.L. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10273-10278
12. Morgan C., Colombres M., Nunez M.T., and Inestrosa N.C. Structure and function of amyloid in Alzheimer's disease. Prog. Neurobiol. 74 (2004) 323-349
13. Morgan D., and Gitter B.D. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease. Neurobiol. Aging 25 (2004) 605-608
14. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego
15. Weiner H.L., and Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol. 6 (2006) 404-416
16. Weksler M.E., Gouras G., Relkin N.R., and Szabo P. The immune system, amyloid-beta peptide, and Alzheimer's disease. Immunol. Rev. 205 (2005) 244-256